Coave Therapeutics

Rodolphe Clerval, CEO

April 20 | 1:45pm | Gaudi 2 Ballroom

Paris, France


In-Person Presentation

Coave Therapeutics is a clinical stage biotechnology company focused on developing life changing gene therapies in rare ocular and CNS diseases. We are pushing the boundaries of gene therapy through application of our AAV-Ligand Conjugates platform that enables targeted delivery, enhanced gene transduction and tissue distribution to improve the effectiveness of advanced gene therapies for rare diseases.

By using this website you agree to accept our Privacy Policy and Terms & Conditions